Hundreds of thousands of clinicians use Eko’s digital stethoscope technology at the point of care to screen patients for cardiopulmonary symptoms:
- Shortness of breath
- Structural heart disease
- Heart failure (pending FDA approval)
- Pulmonary hypertension (algorithm in development)
- Respiratory disease (on roadmap)